Miniaturized Extracorporeal Circulation Study

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 28, 2017

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Coronary Artery Disease
Interventions
PROCEDURE

CABG

"* Cannulation: 24-F arterial cannula, 29/29 F dual-stage venous cannula, and aortic root vent-/cardioplegia cannula~* Grafting: pedicled left internal mammary artery, and no-touch~* saphenous vein graft Heparin and protamine doses assessed by HMS Plus® Hemostasis Management System~* Target activated coagulation time of \>400 seconds"

PROCEDURE

Miniaturized extracorporeal circulation

"* Centrifugal pump to reduce mechanical stress~* Circuit coated with biosurface to increase haemocompatibilty.~* Ante- and retrograde autologous priming and low-volume cardioplegia solution (intermittend cold modified Calafiore) to minimize haemodilution~* Collapsible soft-shell reservoir for blood volume management~* Cell-saving device~* Venous air removing device and electric clamp system to air embolism"

PROCEDURE

Conventional extracorporeal circulation

"* Roller pump~* Circuit uncoated~* Hard-shell venous reservoir~* Intermittend cold blood Harefield cardioplegia"

Trial Locations (1)

8200

Dep. of Cardiothoracic Surgery, Aarhus University Hospital, Aarhus

All Listed Sponsors
lead

Aarhus University Hospital Skejby

OTHER

NCT03216720 - Miniaturized Extracorporeal Circulation Study | Biotech Hunter | Biotech Hunter